#drug safety

A new paper has linked Wegovy to ischemic optic neuropathy, sometimes called an eye stroke, but experts say the evidence is preliminary and the overall rate reported so far remains very low.

Data presented at the American Academy of Neurology meeting suggest Roche’s multiple sclerosis pill outperformed Aubagio on relapse timing, while raising monitoring concerns around liver toxicity.

The FDA has asked Eli Lilly for additional data on its obesity pill Foundayo as the agency evaluates potential risks related to major cardiovascular events and liver damage.

Ipsen is withdrawing Tazverik from the market after a monitoring committee found cases of secondary blood cancers in a confirmatory trial.